000 01474 a2200313 4500
005 20250516124750.0
264 0 _c20130723
008 201307s 0 0 eng d
022 _a1538-7755
024 7 _a10.1158/1055-9965.EPI-12-1263
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerma, Mukesh
245 0 0 _aOpportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.
_h[electronic resource]
260 _bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
_cFeb 2013
300 _a189-200 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aEpigenomics
_xmethods
650 0 4 _aGene Expression Profiling
_xmethods
650 0 4 _aHumans
650 0 4 _aMetabolomics
_xmethods
650 0 4 _aMitochondria
_xgenetics
650 0 4 _aNeoplasms
_xepidemiology
650 0 4 _aTelomerase
_xgenetics
700 1 _aKhoury, Muin J
700 1 _aIoannidis, John P A
773 0 _tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
_gvol. 22
_gno. 2
_gp. 189-200
856 4 0 _uhttps://doi.org/10.1158/1055-9965.EPI-12-1263
_zAvailable from publisher's website
999 _c22348329
_d22348329